非清髓性异基因造血干细胞移植治疗恶性肿瘤
被引量:2
摘要
非清髓性异基因造血干细胞移植 ,主要是通过移植物抗肿瘤效应来根除恶性肿瘤细胞 ,与经典的清髓性异基因造血干细胞移植相比 ,其移植相关并发症和病死率降低 ,对年龄较大。
出处
《国际肿瘤学杂志》
CAS
2005年第1期71-74,共4页
Journal of International Oncology
参考文献21
-
1Renga M,Pedrazzoli P,Siena S.Present results and perspectives of allogeneic non-myeloablative hematopoietic stem cell transplantation for treatment of human solid tumors. Annals of Oncology . 2003 被引量:1
-
2Storb RF,Champlin R,Riddell SR,et al.Non-myeloablative transplants for malignant disease. Hematology . 2001 被引量:1
-
3Champlin R,Khouri I,Anderlini P,et al.Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation Biology and current indications. Oncology Hunting . 2003 被引量:1
-
4Appelbaum FR,Sandmaier B.Sensitivity of renal cell cancer to nonmyeloablative allogeneic hematopoietic cell transplantations: unusual or unsually Important. Journal of Clinical Oncology . 2002 被引量:1
-
5Appelbaum FR.Haematopoietic cell transplantation as immunotherapy. Nature . 2001 被引量:1
-
6Storb RF,Lucarelli G,McSweeney PA,et al.Hematopoietic cell transplantation for benign hematological disorders and solid tumors. Hematology . 2003 被引量:1
-
7Mielcarek M,Martin PJ,Leisenring W,et al.Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood . 2003 被引量:1
-
8Riddell SR,Murata M,Bryant S,et al.Minor histocompatibility antigens-targets of graft versus leukemia responses. International Journal of Hematology . 2002 被引量:1
-
9Tabbara IA,Ingram RM.Nonmyeloablative therapy and allogeneic hematopoietic stem cell transplantation. Experimental Hematology . 2003 被引量:1
-
10Childs RW.Immunotherapy of solid tumors: nonmyeloablative allogeneic stem cell transplantation. Medscape General Medicine . 2002 被引量:1
同被引文献24
-
1刘丽辉,艾辉胜.HLA半相合造血干细胞移植进展[J].国外医学(移植与血液净化分册),2004,2(4):27-30. 被引量:6
-
2胡晶,吴宏.造血干/祖细胞归巢的研究进展[J].国外医学(内科学分册),2005,32(5):195-199. 被引量:3
-
3Chut JP.Stem cell homing.Curr Opin Hematol,2006;13(6):399-406. 被引量:1
-
4Storb RF,Champlin R,Riddell SR,et al.Non-myeloablativetransplants for malignant disease.Hematology Am Soc HematolEduc Program,2001;375-391. 被引量:1
-
5Salem ML,Al-Khami AA,El-Naggar SA,et al.Cyclopho-sphamide induces dynamic alterations in the host microenvironmentsresulting in a Flt3 ligand-dependent expansion of dendritic cells.JImmunol,2010;184(4):1737-1747. 被引量:1
-
6Kohno A, Morishita Y, Lida H, et al. Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission: a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group. Int J Hematol 2008; 87(2):210-216 被引量:1
-
7Lu DP, Dong L, Wu T, et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation.Blood 2006; 107:3065-3073 被引量:1
-
8Bierings M, Nachman JB, Zwaan CM. Stem cell transplantation in pediatric leukemia and myelodysplasia: state of the art and current challenges. Curr Stem Cell Res Ther 2007;2(1):53-63 被引量:1
-
9Kater AP, van Oers MH, Kipps TJ. Cellular immune therapy for chronic lymphocytic leukemia. Blood 2007; 110(8):2811-2818 被引量:1
-
10Ogawa H, Ikegame K, Kaida K, et al. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis. Exp Hematol 2008;36(1): 1-8 被引量:1
引证文献2
-
1陈彩平,陈志哲,黄慧芳,李洁羽,吴正财,何宏星,蔡学瑜,骆晓峰.白血病小鼠单倍型相合骨髓移植的归巢[J].中国组织工程研究与临床康复,2008,12(25):4903-4907. 被引量:2
-
2陈彩平,陈志哲,黄慧芳,蔡学瑜,何宏星,吴正才,骆晓峰.白血病小鼠经不同预处理方案的骨髓移植后移植细胞归巢特点[J].中国实验血液学杂志,2012,20(1):137-141. 被引量:2
二级引证文献3
-
1关雪晶,吴宏.造血干细胞移植后归巢的研究进展[J].医学教育探索,2010,9(1):142-144. 被引量:2
-
2卓海龙,王海平,张雅妮,崔爽,邵春燕,王全立.异体骨髓细胞在不同基因型辐照受鼠中动态分布与迁移规律研究[J].北京医学,2013,35(4):299-302.
-
3降央泽仁,黄茜,黄晓芹.巴桑母酥油丸对放射线-化学复合损伤小鼠造血干细胞移植后重建造血能力的影响[J].中国医药导报,2014,11(4):38-40.
-
1沈悌,张之南.生物治疗——消灭残存肿瘤的新途径[J].中华内科杂志,2000,39(5):293-295. 被引量:1
-
2武利强,张秀侠,周郁鸿.造血干细胞移植在治疗乳腺癌中的应用[J].中华肿瘤防治杂志,2006,13(21):1673-1676. 被引量:2
-
3翟光林,姜藻.移植物抗肿瘤效应及其在实体瘤治疗中的意义[J].东南大学学报(医学版),2004,23(4):282-285.
-
4王顺清,毛平,李庆山,应逸,莫文健,许艳丽,王汉平,庆庆华,谢健晋.非清髓性异基因造血干细胞移植治疗多发性骨髓瘤一例[J].中华肿瘤杂志,2002,24(6):525-525. 被引量:1
-
5耿建,陈龙邦.非清髓性异基因干细胞移植治疗实体瘤的研究进展[J].医学研究生学报,2005,18(2):178-181.
-
6郭宏锋,乔振华,苏丽萍,朱镭,葛晓燕,李蓉萍.非清髓性异基因造血干细胞移植后淋巴细胞重建[J].中华内科杂志,2003,42(5):333-334.
-
7王维,朴大勋.移植物抗肿瘤效应及其应用于大肠癌治疗的研究进展[J].中国普通外科杂志,2011,20(10):1106-1108. 被引量:1
-
8马巧玲,黄勇,阎嶂松,姜尔烈,杨栋林,魏嘉璘,冯四洲,韩明哲.含氟达拉滨的预处理方案移植治疗恶性血液病的临床观察[J].中华血液学杂志,2010,31(2):116-118. 被引量:1
-
9余长林,艾辉胜,王丹红,乔建辉,郭梅,孙万军,张石,侯采妍,姚波.非清髓性异基因外周血造血干细胞移植治疗血液病6例报告[J].中国实验血液学杂志,2001,9(3):282-284. 被引量:1
-
10余家密,陈强,叶韵斌.免疫细胞在移植物抗肿瘤效应中的作用[J].中国肿瘤临床与康复,2007,14(2):167-169. 被引量:2